Back
Las Vegas Sands Vs. Denali Therapeutics Industry Stock Comparison
Buy
57
LVS
Las Vegas Sands
Last Price:
40.79
Seasonality Move:
-0.27%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
Buy
57
Las Vegas Sands (LVS)
is a Buy
Is Las Vegas Sands a Buy, Sell or Hold?
- The current Las Vegas Sands [LVS] share price is $41.40. The Score for LVS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LVS Stock Price Chart
What is Las Vegas Sands's stock price today?
-
The Las Vegas Sands share price today is $41.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
LVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 61.62 | Buy |
Chaikin Money Flow: | 2682236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.2 - 40.74) | Buy |
Bollinger Bands (100): | (39.76 - 45.26) | Sell |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.67 | Buy |
Relative Strength Index (14 RSI): | 77.92 | Buy |
Chaikin Money Flow: | 34344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.24 - 27.72) | Buy |
Bollinger Bands (100): | (18.96 - 25.08) | Buy |
LVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.93 | Buy |
20-day SMA: | 39.95 | Buy |
50-day SMA: | 40.11 | Buy |
200-day SMA: | 46.46 | Sell |
8-day EMA: | 40.14 | Buy |
20-day EMA: | 39.93 | Buy |
50-day EMA: | 40.62 | Buy |
200-day EMA: | 45.13 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28 | Buy |
20-day SMA: | 26.04 | Buy |
50-day SMA: | 24.18 | Buy |
200-day SMA: | 20.53 | Buy |
8-day EMA: | 28.54 | Buy |
20-day EMA: | 26.57 | Buy |
50-day EMA: | 24.56 | Buy |
200-day EMA: | 22.12 | Buy |
Las Vegas Sands Earnings Growth & LVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.18 per share, an increase this year of $0.57 per share, and an increase next year of $0.35 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Las Vegas Sands Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |